ProBioGen adds bioreactors and hunts for staff in €20m investment
CDMO ProBioGen has invested €20m ($26m) in its manufacturing plant in Germany and says it will install two 1,000L single-use bioreactors and employ roughly 75 new staff.
Archives for September 8, 2014
Protalix shares soar… then dive after Ebola drug comments
Protalix shares rocketed 18% then reversed in one weekend after the Israeli protein manufacturer clarified it is not in talks to produce Ebola drug ZMapp.
Analyst: CMOs to prosper as biopharma reduces capacity sharing
Biopharma firms are no longer offering spare capacity to rivals, according to an analyst, who says the trend is benefiting large CMOs.